Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-648-4088Fax+1 214-648-4067
Education & Training
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Gynecologic Pathology, 1995 - 1996
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1992 - 1995- New York-Presbyterian HospitalPost-Doctoral Fellowship, 1986 - 1991
Shanghai Medical UniversityClass of 1982
Certifications & Licensure
CA State Medical License 1996 - Present
TX State Medical License 2016 - 2026
FL State Medical License 2018 - 2020
AZ State Medical License 2005 - 2017
CT State Medical License 2000 - 2006- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Top Pathologist US and World News Reports, 2013
- Top Doctors:Arizona State Castle Connolly, 2013
Publications & Presentations
PubMed
- 1 citationsβ-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions.Maria M Del Mundo, Mitzi Aguilar, Hao Chen, Shuang Niu, Subhransu S Sahoo
International Journal of Gynecological Pathology. 2025-01-01 - miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk.Xia Wang, Ho-Hyung Woo, Michelle Wei, Steven Gibson, Mitzi Miranda
Scientific Reports. 2024-12-02 - FIGO 2023 staging for endometrial cancer, when, if it is not now?Xavier Matias-Guiu, Sigurd Lax, Maria Rosaria Raspollini, Jose Palacios, Wenxin Zheng
European Journal of Cancer. 2024-12-01
Journal Articles
- Metformin Sensitizes Endometrial Cancer Cells to Chemotherapy Through IDH1-Induced Nrf2 Expression via an Epigenetic MechanismWenxin Zheng, MD, Nature
- Superficially Invasive Cervical Squamous Cell Carcinoma Metastatic to Ovarian Endometriotic Cyst Wall, a Case Report and Brief Review of the LiteratureElena Lucas, Wenxin Zheng, Kyle Molberg, BioMed Central
- Combination of TP53 and AGR3 to Distinguish Ovarian High-Grade Serous Carcinoma from Low-Grade Serous CarcinomaWenxin Zheng, MD, Spandidos Publications
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
